XML 42 R30.htm IDEA: XBRL DOCUMENT v3.19.2
Financial Instruments Measured at Fair Value (Tables)
 6 Months Ended
Jun. 29, 2019
Fair Value Disclosures  
Schedule of Fair Value Assets and Liabilities Measured on Recurring Basis Table [Text Block]
The following table presents assets (liabilities) measured at fair value on a recurring basis at June 29, 2019:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents/
other assets
 
$
22,120

 
$
—

 
$
—

 
$
22,120

Equity investments (b)
 
Other assets
 
42,637

 
—

 
—

 
42,637

Interest rate swaps
 
Other liabilities
 
—

 
(9,168
)
 
—

 
(9,168
)
Foreign exchange contracts
 
Other current assets/
other assets
 
—

 
13,122

 
—

 
13,122

Foreign exchange contracts
 
Accrued expenses
 
—

 
(2,950
)
 
—

 
(2,950
)
 
 
 
 
$
64,757

 
$
1,004

 
$
—

 
$
65,761


The following table presents assets (liabilities) measured at fair value on a recurring basis at December 31, 2018:
 
 
Balance Sheet
Location
 
Level 1
 
Level 2
 
Level 3
 
Total
Cash equivalents (a)
 
Cash and cash equivalents/
other assets
 
$
22,883

 
$
—

 
$
—

 
$
22,883

Equity investments (b)
 
Other assets
 
38,045

 
—

 
—

 
38,045

Interest rate swaps
 
Other liabilities
 
—

 
(589
)
 
—

 
(589
)
Foreign exchange contracts
 
Other current assets
 
—

 
4,163

 
—

 
4,163

Foreign exchange contracts
 
Accrued expenses
 
—

 
(2,384
)
 
—

 
(2,384
)
 
 
 
 
$
60,928

 
$
1,190

 
$
—

 
$
62,118


(a)
Cash equivalents include highly liquid investments with an original maturity of less than three months.
(b)
The company has an 8.4% equity ownership interest in Marubun Corporation and a portfolio of mutual funds with quoted market prices. The company recorded an unrealized gain of $8 and $1,842 for the second quarter and six months ended June 29, 2019, respectively, on equity securities held at the end of the quarter. The company recorded an unrealized loss of $4,633 and $7,288 for the second quarter and six months ended June 30, 2018, respectively, on equity securities held at the end of the quarter.

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Text Block]
The effects of derivative instruments on the company’s consolidated statements of operations and other comprehensive income are as follows:
  
 
Quarter Ended
 
Six Months Ended
 
 
June 29,
2019

June 30,
2018
 
June 29,
2019
 
June 30,
2018
Gain (Loss) Recognized in Income
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
774

 
$
6,260

 
$
4,263

 
$
518

Interest rate swaps
 
(322
)
 
(308
)
 
(641
)
 
(611
)
Total
 
$
452

 
$
5,952

 
$
3,622

 
$
(93
)
Gain (Loss) Recognized in Other Comprehensive Income before reclassifications, net of tax
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
$
1,294

 
$
(58
)
 
$
7,247

 
$
(1,135
)
Interest rate swaps
 
(6,849
)
 
—

 
(6,849
)
 
—

Total
 
$
(5,555
)
 
$
(58
)
 
$
398

 
$
(1,135
)
Foreign Exchange Contract [Member] | Designated as Hedging Instrument [Member]  
Fair Value Disclosures  
Description of Derivative Hedging Instruments
During the first quarter of 2019, the company entered into a series of foreign exchange contracts to sell Euro and buy United States Dollars, with various maturity dates as noted in the table below:
Maturity Date
 
Notional Amount
March 2023
 
EUR 50,000
September 2024
 
EUR 50,000
April 2025
 
EUR 100,000
January 2028
 
EUR 100,000
Total
 
EUR 300,000
Interest Rate Swap [Member] | Designated as Hedging Instrument [Member]  
Fair Value Disclosures  
Description of Derivative Hedging Instruments

As of June 29, 2019 and December 31, 2018, the company had one outstanding interest rate swap designated as a fair value hedge, the terms of which are as follows:
Maturity Date
 
Notional Amount
 
Interest rate due from counterparty
 
Interest rate due to counterparty
April 2020
 
50,000
 
6.000%
 
6 mo. USD LIBOR + 3.896%